Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Trainer

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Clinical Endocrinology|June 26, 1998
Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adultsJ Rodríguez-Arnao, I James, A Jabbar, et al.
Clinical Endocrinology|July 9, 2002
Gender and age influence the relationship between serum GH and IGF-I in patients with acromegalyC Parkinson, A G Renehan, W D J Ryder, et al.
Clinical Endocrinology|December 14, 1999
Quantitative growth hormone secretion and final adult heightP J Trainer, M Palermo, J M Kirk, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 1999
The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressinM Korbonits, G Kaltsas, L A Perry, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegalyP J Trainer, W M Drake, L A Perry, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
The pathophysiology of circulating corticotropin-releasing hormone-binding protein levels in the humanP J Trainer, R J Woods, M Korbonits, et al.
Clinical Endocrinology|July 17, 2003
The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegalyC Parkinson, A J Whatmore, A P Yates, et al.
Clinical Endocrinology|April 1, 1991
The effects on anterior pituitary hormone secretion of salmon calcitonin in healthy volunteersP J Trainer, J M Kirk, L McLoughlin, et al.
Clinical Endocrinology|September 1, 1999
Hexarelin as a test of pituitary reserve in patients with pituitary diseaseM Korbonits, G Kaltsas, L A Perry, et al.
Endocrine Connections|June 23, 2018
SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapyC E Higham, A Olsson-Brown, P Carroll, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Clinical Endocrinology|June 26, 1998
Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adultsJ Rodríguez-Arnao, I James, A Jabbar, et al.
Clinical Endocrinology|July 9, 2002
Gender and age influence the relationship between serum GH and IGF-I in patients with acromegalyC Parkinson, A G Renehan, W D J Ryder, et al.
Clinical Endocrinology|December 14, 1999
Quantitative growth hormone secretion and final adult heightP J Trainer, M Palermo, J M Kirk, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 1999
The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressinM Korbonits, G Kaltsas, L A Perry, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegalyP J Trainer, W M Drake, L A Perry, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
The pathophysiology of circulating corticotropin-releasing hormone-binding protein levels in the humanP J Trainer, R J Woods, M Korbonits, et al.
Clinical Endocrinology|July 17, 2003
The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegalyC Parkinson, A J Whatmore, A P Yates, et al.
Clinical Endocrinology|April 1, 1991
The effects on anterior pituitary hormone secretion of salmon calcitonin in healthy volunteersP J Trainer, J M Kirk, L McLoughlin, et al.
Clinical Endocrinology|September 1, 1999
Hexarelin as a test of pituitary reserve in patients with pituitary diseaseM Korbonits, G Kaltsas, L A Perry, et al.
Endocrine Connections|June 23, 2018
SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapyC E Higham, A Olsson-Brown, P Carroll, et al.
Pageof 11